Ftse Mib
34.728,68
0,93%
DAX
19.473,63
1,32%
S&P 500
5.742,27
-0,05%
NASDAQ
18.084,93
-0,58%
Bitcoin
65.851,19
1,02%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cidara Therapeutics Inc (CDTX) Cidara Therapeutics Inc (CDTX) Notizie

CDTX

Cidara Therapeutics (CDTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CDTX
DataOraFonteTitoloSimboloCompagnia
23/09/202414:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
14/09/202400:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
13/08/202422:35Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CDTXCidara Therapeutics Inc
31/07/202423:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CDTXCidara Therapeutics Inc
29/07/202422:45Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CDTXCidara Therapeutics Inc
19/07/202422:54Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CDTXCidara Therapeutics Inc
03/06/202422:38Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CDTXCidara Therapeutics Inc
03/06/202422:36Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CDTXCidara Therapeutics Inc
23/05/202422:59Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CDTXCidara Therapeutics Inc
02/11/202321:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDTXCidara Therapeutics Inc
01/08/202316:30AllPennyStocks.comBiotech Rallies Right Before Opening BellNASDAQ:CDTXCidara Therapeutics Inc
23/06/202323:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDTXCidara Therapeutics Inc
23/06/202322:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDTXCidara Therapeutics Inc
11/05/202322:13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CDTXCidara Therapeutics Inc
27/04/202322:44Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CDTXCidara Therapeutics Inc
27/04/202322:43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CDTXCidara Therapeutics Inc
23/03/202315:19GlobeNewswire Inc.5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough ScienceNASDAQ:CDTXCidara Therapeutics Inc
23/03/202312:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CDTXCidara Therapeutics Inc
06/03/202322:27Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CDTXCidara Therapeutics Inc
14/02/202323:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CDTXCidara Therapeutics Inc
25/01/202321:40AllPennyStocks.comAnother Biotech Steals The ShowNASDAQ:CDTXCidara Therapeutics Inc
02/12/202214:35TipRanksH.C. Wainwright Keeps Their Buy Rating on Cidara Therapeutics (CDTX)NASDAQ:CDTXCidara Therapeutics Inc
31/10/202222:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CDTXCidara Therapeutics Inc
21/09/202212:25TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Cidara Therapeutics (CDTX)NASDAQ:CDTXCidara Therapeutics Inc
21/09/202211:55TipRanksNeedham Remains a Buy on Cidara Therapeutics (CDTX)NASDAQ:CDTXCidara Therapeutics Inc
14/09/202214:41TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Cidara Therapeutics (CDTX) and Akero Therapeutics (AKRO)NASDAQ:CDTXCidara Therapeutics Inc
11/08/202213:15TipRanksMaxim Group Keeps Their Buy Rating on Cidara Therapeutics (CDTX)NASDAQ:CDTXCidara Therapeutics Inc
28/07/202212:26TipRanksH.C. Wainwright Remains a Buy on Cidara Therapeutics (CDTX)NASDAQ:CDTXCidara Therapeutics Inc
10/07/202214:05TipRanksH.C. Wainwright Thinks Cidara Therapeutics’ Stock is Going to RecoverNASDAQ:CDTXCidara Therapeutics Inc
08/07/202211:35TipRanksNeedham Thinks Cidara Therapeutics’ Stock is Going to RecoverNASDAQ:CDTXCidara Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CDTX

La tua Cronologia

BIT
MONC
Moncler
BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
PRY
Prysmian
BIT
SPM
Saipem
BIT
CPR
Davide Campari
BIT
BC
Brunello Cucinelli
BIT
TEN
Tenaris
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network